| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Mitogen-activated protein kinase 3 |
|---|
| Ligand | BDBM50427363 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_941104 (CHEMBL2330901) |
|---|
| Ki | >1000±n/a nM |
|---|
| Citation |  Jimenez, JM; Boyall, D; Brenchley, G; Collier, PN; Davis, CJ; Fraysse, D; Keily, SB; Henderson, J; Miller, A; Pierard, F; Settimo, L; Twin, HC; Bolton, CM; Curnock, AP; Chiu, P; Tanner, AJ; Young, S Design and optimization of selective protein kinase C¿ (PKC¿) inhibitors for the treatment of autoimmune diseases. J Med Chem56:1799-810 (2013) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Mitogen-activated protein kinase 3 |
|---|
| Name: | Mitogen-activated protein kinase 3 |
|---|
| Synonyms: | ERK1 | ERK1/ERK2 | Extracellular signal-regulated kinase 1 | Extracellular signal-regulated kinase 1 (ERK1) | MAP kinase ERK1 | MAPK3 | MAPK3/MAPK7 | MK03_HUMAN | Mitogen-activated protein kinase | Mitogen-activated protein kinase 3 | PRKM3 |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 43136.58 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | curated by PDB 4QTB |
|---|
| Residue: | 379 |
|---|
| Sequence: | MAAAAAQGGGGGEPRRTEGVGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAY
DHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYI
VQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDL
KICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS
NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSD
SKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFAMELDDLPKERL
KELIFQETARFQPGVLEAP
|
|
|
|---|
| BDBM50427363 |
|---|
| n/a |
|---|
| Name | BDBM50427363 |
|---|
| Synonyms: | CHEMBL2326002 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C20H24ClFN6O |
|---|
| Mol. Mass. | 418.896 |
|---|
| SMILES | CC(C)[C@@](C)(O)[C@@H]1CN(CCN1)c1nc(-c2n[nH]c3ncccc23)c(F)cc1Cl |r| |
|---|
| Structure | 
|
|---|
Search and Browse
